Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Van der Heijden; Johannes A. M.
Address:
Weesp, NL
No. of patents:
7
Patents:












Patent Number Title Of Patent Date Issued
7605162 Phenylpiperazine October 20, 2009
The invention relates to a novel group of phenylpiperazines having interesting pharmacological properties such as a high affinity for the dopamine D.sub.2 receptor and/or the serotonin reuptake site, and the ability to treat conditions related to disturbances in the dopaminergic and/
7456182 Phenylpiperazines November 25, 2008
The invention relates to a novel group of phenylpiperazines having interesting pharmacological properties such as a high affinity for the dopamine D.sub.2 receptor and/or the serotonin reuptake site, and the ability to treat conditions related to disturbances in the dopaminergic and/
7297699 Piperazine and piperidine compounds November 20, 2007
The invention relates to a group of novel piperazine and piperidine derivatives of the formula wherein Y is hydrogen, halogen, alkyl (1-3C), or CN, CF.sub.3, OCF.sub.3, SCF.sub.3, alkoxy(1-3C), amino or mono- or dialkyl(1-3C) substituted amino or hydroxy, X is O, S, SO or SO.sub.2, -
7067513 Phenylpiperazines June 27, 2006
The invention relates to a novel group of phenylpiperazines having interesting pharmacological properties such as a high affinity for the dopamine D.sub.2 receptor and/or the serotonin reuptake site, and the ability to treat conditions related to disturbances in the dopaminergic and/
6911448 Piperazine and piperidine compounds June 28, 2005
The invention relates to a group of novel piperazine and piperidine derivatives of the formula wherein Y is hydrogen, halogen, alkyl (1-3C), or CN, CF.sub.3, OCF.sub.3, SCF.sub.3, alkoxy(1-3C), amino or mono- or dialkyl(1-3C) substituted amino or hydroxy, X is O, S, SO or SO.sub.2, -
6780864 Piperazine and piperidine compounds August 24, 2004
The invention relates to a group of novel piperazine and piperidine derivatives of formula (I), wherein: S.sub.1 is hydrogen, halogen, alkyl (1-3C), CN, CF.sub.3, OCF.sub.3, SCF.sub.3, alkoxy (1-3C), amino or mono- or dialkyl (1-3C) substituted amino, or hydroxy; X represents NR.sub.3, S
6391896 3-Tetrahydropyridin-4-yl indoles for treatment of psychotic disorders May 21, 2002
The invention is related to the following compounds: ##STR1##wherein all variables are as defined in the specification. The compounds are useful for treating psychotic disorders.










 
 
  Recently Added Patents
Composition for enhancing memory and mitigating neurodegeneration and method thereof
Semiconductor integrated circuit
FET device having ultra-low on-resistance and low gate charge
Method for editing a media clip in a mobile terminal device, a terminal device utilizing the method and program means for implementing the method
Cell reselection and handover with multimedia broadcast/multicast service
Antibodies to non-functional P2X.sub.7 receptor
Deposition apparatus and method for manufacturing organic light emitting diode display using the same
  Randomly Featured Patents
Organic electroluminescence device
Method of making a thin film transistor by overlapping annealing using lasers
Device for entanglement of filaments in a multifilament yarn
Solid-state high-luminance far ultraviolet light emitting element including highly pure hexagonal boron nitride single crystal
Process for identifying an incorrectly measuring sensor in a spacecraft
Frame handling system, and frame handling method
Plasma processing systems
Glucose conversion to ethanol via yeast cultures and bicarbonate ions
Mesenchymal stem cells expressing TNF-alpha receptors
Three dimensional tactile seam tracing device